N-(5-{4-Chloro-3-[(2-hydroxyethyl)sulfamoyl]phenyl}-4-methyl-1,3-thiazol-2-yl)acetamide

Star0

DB06836ExperimentalSmall molecule

N-(5-{4-Chloro-3-[(2-hydroxyethyl)sulfamoyl]phenyl}-4-methyl-1,3-thiazol-2-yl)acetamide: Overview.

Formula / weight: C₁₄H₁₆ClN₃O₄S₂ · 389.878 g/mol (avg)

Resolves to

Compound

UNIIQS3XFL5JRXCAS593960-11-3ChEMBLCHEMBL1229535PubChem6852167

Structure

InChIKeyJFVNFXCESCXMBC-UHFFFAOYSA-NSMILES[H]N(CCO)S(=O)(=O)C1=C(Cl)C=CC(=C1)C1=C(C)N=C(S1)N([H])C(C)=O

Targets

Q9UBF8PI4KBP48736PIK3CGQ8NEB9PIK3C3

What you can answer from here — as of April 02, 2025

3Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

10+ReferencesStructured and connected to the statements they support

Which drugs share a target with N-(5-{4-Chloro-3-[(2-hydroxyethyl)sulfamoyl]phenyl}-4-methyl-1,3-thiazol-2-yl)acetamide, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account